期刊文献+

流通池法在泊沙康唑口服混悬液体外溶出研究中的应用 被引量:2

Application of flow-through cell apparatus in the in vitro dissolution of posaconazole oral suspension
下载PDF
导出
摘要 目的建立一种有区分力的流通池法检查泊沙康唑口服混悬液的体外溶出。方法以研磨法制成不同粒度分布的泊沙康唑混悬液中间体,并通过调节辅料黄原胶的加入量,制备成具有不同粒度分布和不同黏度的泊沙康唑口服混悬液。对关键参数(玻璃珠用量、加样方式以及流速)进行筛选,建立检查泊沙康唑口服混悬液体外溶出的流通池法。用新建立的流通池法和FDA溶出度数据库收载的桨法分别检测泊沙康唑口服混悬液的体外溶出曲线。结果桨法测得的溶出曲线药物释放较快,20 min时已基本释放完全;而新建立的流通池法测得的溶出曲线药物释放缓慢,并且对混悬液的粒度分布和黏度差异显示出良好的区分力。结论与桨法相比,流通池法检查泊沙康唑口服混悬液的体外溶出时具有更高的区分力。 Objective To establish flow-through cell apparatus to test the in vitro dissolution of posaconazole oral suspension with good discrimination.Methods Posaconazole suspension intermediates with different particle sizes were prepared by bead-milling method.Posaconazole oral suspensions with different particle sizes and viscosities were prepared by adjusting the amount of addition in excipient xanthan gum.The flow-through cell apparatus for testing the dissolution of posaconazole oral suspension was established by screening the key parameters:the amount of glass beads,the way of adding samples and the flow rate.The in vitro dissolution profiles of the posaconazole oral suspensions were tested by the newly constructed flow-through cell apparatus and the paddle apparatus recorded in the FDA dissolution methods database.Results The dissolution profiles measured by the paddle apparatus showed faster release of the drug,and the drug was released at most completely at 20 min;while the newly established flow-through cell apparatus demonstrated slow release,with good discrimination for the particle size and viscosity of the suspension.Conclusion Compared with the paddle apparatus,the flow-through cell apparatus has better discrimination for the in vitro dissolution of posaconazole oral suspension.
作者 刘德鹏 李倩 郝贵周 丁静雯 张贵民 LIU De-peng;LI Qian;HAO Gui-zhou;DING Jing-wen;ZHANG Gui-min(National Engineering and Technology Research Center of Chirality Pharmaceuticals,Lunan Pharmaceutical Group Co.,Ltd.,Linyi Shandong 273400)
出处 《中南药学》 2023年第8期2083-2087,共5页 Central South Pharmacy
关键词 流通池法 区分力 泊沙康唑口服混悬液 体外溶出 flow-through cell apparatus discrimination posaconazole oral suspension in vitro dissolution
  • 相关文献

参考文献6

二级参考文献39

  • 1夏路风,刘蕾,傅得兴.新型广谱三唑类抗真菌药泊沙康唑[J].中国新药杂志,2007,16(15):1226-1231. 被引量:8
  • 2Adkins JC, Faulds D. Micronized fenofibrate. A review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidemia[J]. Drugs, 1997,54 (4) : 615.
  • 3Elaine ML. Nanocrystals : Resolving Pharmaceutical Formulation lssues Associated with Poorly Water-soluble Compounds[M]. Orlando Florida: Marcel Dekker Press, 2002 : 45.
  • 4Elaine ML, Gary GL, Eugene RC. Nanosizing: a formulation approach for poorly-water-soluble compounds[J]. European Journal of Pharmaceutical Sciences, 2003, 2 (18):113.
  • 5Grenier P, Vergnault G, Nhamias A. Nanoparticulateformulations of fenofibrate[P]. USA: 20050095297.2005- 05-05.
  • 6张玉,唐凤敏,马力.高效液相色谱法测定布洛芬混悬液中布洛芬含量[J].中国医院药学杂志,2007,27(11):1537-1538. 被引量:5
  • 7Kantor TG. Ibuprofen-past, present and future [ J ]. Am J Med, 1984, 77(1A) : 121-125.
  • 8国家食品药品监督管理局药品审评中心.普通口服固体制剂溶出度试验技术指导原则[EB/OL].http://www.sda.gov.cn/WS01/CLl616/114288.html,2015-02-05/2016-04-28.
  • 9Chu KR, Lee E, Jeong SH. Effect of particle size on the dissolution behaviors of poorly water-soluble drugs [ J]. Arch Pharm Res, 2012, 35(7) : 1187-1195.
  • 10USP38 [ S]. 2015 年版. 3471-3472.

共引文献36

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部